CAS 2253744-59-9

1,4-Butanediamine, N1-[[4-[[(1H-imidazol-2-ylmethyl)[(1-methyl-1H-imidazol-2-yl)methyl]amino]methyl]phenyl]methyl]-N1-methyl-N4,N4-dipropyl-, hydrochloride (1:3)

Description:

1,4-Butanediamine, N1-[[4-[[(1H-imidazol-2-ylmethyl)[(1-methyl-1H-imidazol-2-yl)methyl]amino]methyl]phenyl]methyl]-N1-methyl-N4,N4-dipropyl-, hydrochloride (1:3) is a complex organic compound characterized by its multi-functional amine structure. It features a butanediamine backbone, which provides two amine groups, enhancing its potential for forming hydrogen bonds and participating in various chemical reactions. The presence of imidazole rings contributes to its biological activity, as imidazole is often found in biologically relevant molecules, including amino acids and nucleotides. The compound is likely to exhibit solubility in polar solvents due to its amine and hydrochloride functionalities, which can facilitate ionic interactions. Its hydrochloride salt form suggests enhanced stability and solubility in aqueous environments. This compound may have applications in pharmaceuticals or biochemistry, particularly in drug design or as a biochemical probe, owing to its structural complexity and potential interactions with biological targets. However, specific safety and handling guidelines should be followed due to the presence of amine groups, which can be reactive.

Formula: C₂₈H₄₆ClN₇

Synonyms:

• 1,4-Butanediamine, N1-[[4-[[(1H-imidazol-2-ylmethyl)[(1-methyl-1H-imidazol-2-yl)methyl]amino]methyl]phenyl]methyl]-N1-methyl-N4,N4-dipropyl-, hydrochloride (1:3)

KRH-3955 hydrochloride

CAS: 2253744-59-9

KRH-3955 hydrochloride is an orally available CXCR4 blocker with IC50 of 0.61 nM and EC50 of 0.3-1.0 nM against X4 HIV-1.

Formula: C₂₈H₄₈Cl₃N₇

Color and Shape: Solid

Molecular weight: 589.09

Ref: TM-T39787